Genta Genasense Confirmatory Chronic Leukemia Trial To Begin By Year End
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Genta plans to launch a confirmatory trial of Genasense (oblimersen sodium) in chronic lymphocytic leukemia (CLL) before the end of 2005, the firm says.